|
|
|
|
Tracleer® About Tracleer® Tracleer® (bosentan) is an orally active dual endothelin receptor antagonist (ERA). Tracleer® works by blocking the binding of endothelin (ET). ET is ... http://www.actelion.com/uninet/www/www_main_p.nsf/Content/Marketed+Products+Fact+Sheet/$FILE/081021_Marketed_Product_FS.pdfCombination Estrogen/Progestogen Patch (U.S.) Marketed by Novogyne Pharmaceuticals Estradot ® (estradiol transdermal system) World's Smallest Transdermal Estrogen Patch ... http://www.noven.com/profile.htmIt's flawed. As dated as Napster or acid wash jeans. Coveting the American family has been the preferred marketing model since the Disco '70s, when NASL pioneers fanned out to ... http://soccernet.espn.go.com/columns/story?id=487388&root=mls&cc=5901If the serious adverse event is associated with an OTC drug product(s) marketed without an approved application and a dietary supplement(s) that is also manufactured, packaged ... http://www.fda.gov/cder/guidance/7950dft.htm ... of aplastic anemia in the setting of refractory or prolonged myelosuppression in patients receiving temozolomide and report cases to FDA's MedWatch. Temozolomide, marketed in the ... http://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm |
|
|